Review
New opportunities for the development of cancer immunotherapies
Affiliations
- PMID: 9619263
Item in Clipboard
Review
New opportunities for the development of cancer immunotherapies
Cancer J Sci Am.
1998 May.
No abstract available
Similar articles
-
Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer.Cancer J Sci Am. 2000 Feb;6 Suppl 1:S2-7. Cancer J Sci Am. 2000. PMID: 10685650 Review. No abstract available.
-
Translation of cancer immunotherapies.Nat Med. 2004 Nov;10(11):1154-5; author reply 1155. doi: 10.1038/nm1104-1154. Nat Med. 2004. PMID: 15516901 No abstract available.
-
Translation of cancer immunotherapies.Nat Med. 2004 Nov;10(11):1153; author reply 1153-4. doi: 10.1038/nm1104-1153a. Nat Med. 2004. PMID: 15516900 No abstract available.
-
[Cytotoxic T-cell immune response against melanoma antigens].Ann Dermatol Venereol. 1998 Nov;125 Suppl 2:S34-6. Ann Dermatol Venereol. 1998. PMID: 9922891 French. No abstract available.
-
Progress in human tumour immunology and immunotherapy.Nature. 2001 May 17;411(6835):380-4. doi: 10.1038/35077246. Nature. 2001. PMID: 11357146 Review.
Cited by
-
DNA vaccines to attack cancer.Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14646-52. doi: 10.1073/pnas.0404896101. Epub 2004 Aug 3. Proc Natl Acad Sci U S A. 2004. PMID: 15292504 Free PMC article. Review.
-
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.J Exp Med. 1999 Dec 6;190(11):1669-78. doi: 10.1084/jem.190.11.1669. J Exp Med. 1999. PMID: 10587357 Free PMC article. Clinical Trial.
-
Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.Ann Surg. 2002 Apr;235(4):540-9. doi: 10.1097/00000658-200204000-00013. Ann Surg. 2002. PMID: 11923611 Free PMC article. Clinical Trial.